Clinical Trials and Research Studies: GLA:D™ is based on extensive research and clinical trials conducted in Denmark. The program’s effectiveness has been demonstrated through various studies that assessed its impact on pain reduction, functional improvement, and patient satisfaction.
International Adoption and Adaptation: The success of GLA:D™ in Denmark has led to its adoption and adaptation in other countries. Many healthcare professionals worldwide have implemented the program, and positive outcomes have been reported in different cultural and healthcare settings.
Patient-reported Outcomes: Studies and evaluations of GLA:D™ have included patient-reported outcomes, where individuals participating in the program provide feedback on their experiences, pain levels, and improvements in function. Positive responses from participants contribute to the evidence supporting the program.
Recommendations by Health Organizations: Some health organizations and professional societies endorse and recommend GLA:D™ as a beneficial intervention for individuals with hip and knee osteoarthritis. This endorsement adds to the credibility and evidence supporting the program.
Long-term Follow-up Data: Some studies have included long-term follow-up data, providing insights into the sustainability of the benefits gained from participating in the GLA:D™ program. Long-term data is valuable in assessing the lasting impact of the intervention.
It’s important to note that evidence supporting GLA:D™ may vary in terms of study design, population characteristics, and specific outcomes measured. Healthcare professionals interested in implementing or recommending GLA:D™ should consider reviewing the relevant literature and consulting with experts in the field. Additionally, individual responses to the program may vary, and healthcare decisions should be personalized based on a patient’s specific needs and circumstances.